Evidence map›Paper›PMID 38713304›Full record

ArticleInflammation2024

Esaxerenone Inhibits Interferon-γ Induced Pyroptosis of Macrophages in the Lungs of Aldosterone-treated Mice.

Jingyue Chang, Xiaomeng Gao, Fan Yang, Panpan Qiang, Lili Fan, Ziqian Liu, Tatsuo Shimosawa, Qingyou Xu, Yi Chang

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jingyue Chang *Graduate School, Hebei University of Chinese Medicine, Shijiazhuang, 050200, China.
Xiaomeng Gao *Graduate School, Hebei University of Chinese Medicine, Shijiazhuang, 050200, China.
Fan Yang *Hebei Key Laboratory of Integrative Medicine on Liver-Kidney Patterns, Hebei University of Chinese Medicine, Shijiazhuang, 050200, China.
Panpan QiangHebei Key Laboratory of Integrative Medicine on Liver-Kidney Patterns, Hebei University of Chinese Medicine, Shijiazhuang, 050200, China.
Lili FanGraduate School, Hebei University of Chinese Medicine, Shijiazhuang, 050200, China.
Ziqian LiuGraduate School, Hebei University of Chinese Medicine, Shijiazhuang, 050200, China.
Tatsuo ShimosawaDepartment of Clinical Laboratory, School of Medicine, International University of Health and Welfare, Narita, 286-8686, Japan.
Qingyou XuGraduate School, Hebei University of Chinese Medicine, Shijiazhuang, 050200, China. qingyouxu@hebcm.edu.cn.
Yi ChangHebei Key Laboratory of Integrative Medicine on Liver-Kidney Patterns, Hebei University of Chinese Medicine, Shijiazhuang, 050200, China. changyiyi@hebcm.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung immune cells such as lymphocytes and macrophages can induce an inflammatory response due to the activation of mineralocorticoid receptor (MR), which is manifested by the infiltration of inflammatory cells and the secretion of inflammatory cytokines and subsequent apoptosis, pyroptosis and necrosis of intrinsic lung cells and immune cells. Macrophages are immune cells that are abundant in the lung and act as the first line of defense against pathogens but are also aggravating factors of infection. The activation of the renin-angiotensin-aldosterone system (RAAS), especially aldosterone-stimulated MR activation, can induce macrophage and CD8

Indexed as

AldosteroneInterferon-gammaLungMacrophagesMice, Inbred C57BLPyroptosisAnimalsMaleMicePyrrolesSulfonesAldosteroneesaxerenoneInterferon-gammaPyrrolesSulfonesaldosteroneinterferon-gammalung injurymacrophage pyroptosismineralocorticoid receptor blocker

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.